Study on the prescription of thromboembolic disease prophylaxis in pregnant women
DOI:
https://doi.org/10.35954/SM2021.40.1.3Keywords:
Platelet Aggregation; Pulmonary Embolism; Maternal Mortality; Pregnant Women; Postpartum Period; Antiphospholipid Syndrome; ThrombophiliaAbstract
ABS Venous thromboembolic disease is an important cause of morbimortality in pregnant or puerperal women. The general objective of this study is to evaluate the frequency of thromboprophylaxis prescription according to current guidelines, among pregnant and puerperal women attended in the Obstetrics ward and in the Obstetric Moderate Care Unit. Material and methods: in a first stage, a retrospective descriptive study was carried out, where the medical records of pregnant and puerperal women hospitalized for obstetric or non-obstetric causes during the period 2017 - 2018 were analyzed. It was recorded whether or not those patients had contraindications for thromboprophylaxis. In a second stage, a simplified thromboprophylaxis guide was provided to the treating physicians. Results: out of 214 pregnant and puerperal pregnant women hospitalized, 53% had risk factors for thromboembolic disease and 93% of them did not receive thromboprophylaxis. In the second stage of the study, when the treating physicians were given a simplified thromboprophylaxis guide, it was observed that: the prescription of thromboprophylaxis for pregnant women at intermediate risk increased to 80% during pregnancy and to 100% in the puerperium. The prescription of thromboprophylaxis for pregnant women with 2 or more risk factors for thromboembolic disease increased 90% during pregnancy and 100% during the puerperium. Conclusions: combining multiple interventions such as the implementation of written or electronic alerts in the medical record, together with the awareness of health personnel, through continuous medical education, increases the prescription of thromboprophylaxis to women with risk factors for thromboembolic disease during pregnancy and puerperium.Study on the prescription of thromboembolic disease prophylaxis in pregnant women.
Received for review: October 2020.
Accepted for publication: January 2021.
Correspondence: 8 de Octubre 3020.C.P. 11300. Montevideo, Uruguay. Tel: (+598)24876666 ext. 3330.
Contact e-mail: anabelafm@telefonica.net
Downloads
Metrics
References
(1) Grupo de Trabajo de la Sociedad Europea de Cardiología (ESC) sobre el Tratamiento de las Enfermedades Cardiovasculares durante el Embarazo. Guía ESC 2018 sobre el tratamiento de las enfermedades cardiovasculares durante el embarazo. Rev Esp Cardiol 2019; 72(2):161.e1-e65. doi: 10.1016/j.recesp.2018.12.004
(2) Royal College of Obstetricians and Gynaecologists. Thromboembolic disease in pregnancy and the puerperium: acute management. In: Green-Top. Guideline Nº 37b. London : RCOG; 2015.
(3) Sultan AA, Tata LJ, West J, Fiaschi L, Fleming KM, Nelson-Piercy C, Grainge MJ. Risk factors for first venous thromboembolism around pregnancy: A population based cohort study from the United Kingdom. Blood 2013; 121(19):3953-3961. doi: 10.1182/blood-2012-11-469551
(4) Gader A, Elrahium A, Adam I. Epidemiology of Deep venous thrombosis during pregnancy and puerperium in sudanese women. Vasc Health Risk Manag 2009; 5(1):85-7. PMID: 19436646.
(5) Rosenberg VA, Lockwood CJ. Thromboembolism in pregnancy. Obstet Gynecol Clin North Am 2007; 34(3):481-500, xi. doi: 10.1016/j.ogc.2007.06.006
(6) Latino JO, coord. Trombofilia en edad reproductiva. Consenso FASGO 2015.17 p. Disponible en: http://www.fasgo.org.ar/archivos/consensos/Consenso_Obstetricia_TROMBOFILIA_EN_EDAD_REPRODUCTIVA.pdf [Consulta 20/02/2019]
(7) Protocolo: Tromboembolismo venoso en la gestación y el puerpério. Hospital Clinic, Hospital Sant Joan de Déu, Universitat de Barcelona. 16 p. Disponible en: https://medicinafetalbarcelona.org/protocolos/es/patologia-materna-obstetrica/tromboembolismo-venoso-gestacion-puerperio.html [Consulta 21/02/2019]
(8) McLintock C, Brighton T, Chunilal S, Dekker G, McDonnell N, McRae S, et al. Recommendations for the prevention of pregnancy-associated venous thromboembolism. Aust N Z J Obstet Gynaecol 2012; 52(1):3-13. doi: 10.1111/j.1479-828X.2011.01357.x
(9) Latino JO, coord. Consenso S.O.G.I.B.A. 2017 – Tromboprofilaxis durante el parto y puerperio. 22 p. Disponible en: http://www.fasgo.org.ar/images/Consenso_SOGIBA_2017_Obstetricia.pdf [Consulta 14/02/2020]
(10) Gazitúa R, Saavedra S, Conte G, Figueroa G. Tromboprofilaxis en pacientes médicos hospitalizados. ¿A todos por igual? Rev Hosp Clin Univ Chile [internet]. 2015 [citado 02-02-2019]; 26:185-197. Disponible en: https://www.redclinica.cl/Portals/0/Users/014/14/14/tromboprofilaxis_pacientes_hospitalizados.pdf
(11) The American College of Obstetricians and Gynaecologists. Practice Bulletin Nº 196. Practice Guideline Obstet Gynecol 2018; 132(1):243-248. doi: 10.1097/AOG.0000000000002707
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 Anabela Fernández, Jorge Castelli, Ignacio Álvez. The authors retain their copyright and grant the journal the right of first publication of their work, which will be simultaneously subject to the Creative Commons Attribution 4.0 International License that allows sharing the work as long as the initial publication in this journal is indicated.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Until 2024 we use the Creative Commons Attribution/NonCommercial Attribution 4.0 International License https://creativecommons.org/licenses/by-nc/4.0/deed.es. Which states that: you are free to share, copy and redistribute the material in any medium or format, as well as to adapt, remix, transform and build upon the material. Under the following terms:
Attribution: you must give proper credit , provide a link to the license, and indicate if changes have been made . You may do so in any reasonable manner, but not in such a way as to suggest that you or your use is endorsed by the licensor.
NonCommercial: you may not use the material for commercial purposes.
As of 2025 authors retain their copyright and assign to the journal the right of first publication of their work, which shall simultaneously be subject to the license https://creativecommons.org/licenses/by-nc-sa/4.0/deed.es that permits sharing, copying and redistribution of the material in any medium or format provided that initial publication in this journal is indicated. Adapt, remix, transform and build upon the material. If you remix, transform, or build from the material, you must distribute your contribution under the same license as the original and may not make use of the material for commercial purposes.
Under the following terms:
1. Attribution: you must give proper credit, provide a link to the license, and indicate whether changes have been made. You may do so in any reasonable manner, but not in such a way as to suggest that you or your use is endorsed by the licensor.
2. NonCommercial: you may not use the material for commercial purposes.
3. ShareAlike: if you remix, transform or build upon the material, you must distribute your contribution under the same license as the original.
PlumX Metrics
/
